News
Focus on the diagnosis of pathogenic microorganisms in the reproductive tract and respiratory tract
Medomics Medical has awarded the EU CE certificate of the SARS-CoV-2 and Influenza A/B Antigen Combo rapid Test Kit (LFIA)
2022-07-19 10:02:32
On May 24th, Medomics Medical independently developed SARS-CoV-2 &Influenza A/B Antigen Combo Rapid Test Kit(LFIA) that can be used for this self test rapid combo has obtained the CE self-test certificate issued by PCBC (1434), which means that Medomics Medical's triple inspection and self-test products have fully complied with the IVDD directive and the latest EU MDCG2021-21 Regulatory requirements, it can be sold in the EU and countries that recognize the EU CE self-test certificate. Medomics is the third IVD company to obtain the CE certificate of triple inspection and self-test, and the first company in the world to pass the audit and certification of this self test rapid combo inspection and self-test certificate by the well-known announcement agency UL.

Related News
2026-08-19
EXPOPHARM 2026 | Munich, Germany
2026-08-14
2026-03-27
Medomics Participates in MEDICA 2025
2025-12-05
Medomics at Global Health Exhibition 2025
2025-11-03